A short segment in the HIV-1 gp120 V1/V2 region is a major determinant of neutralization resistance to PG9-like antibodies

Por Doria-Rose NA, Georgiev I, Staupe RP, O'Dell S, Chuang G, Gorman J, McLellan JS, Pancera M, Bonsignori M, Haynes BF, Burton DR, Koff WC, Kwong PD, Mascola JR
Publicado em 2012-09-01

A short segment in the HIV-1 gp120 V1/V2 region is a major determinant of neutralization resistance to PG9-like antibodies

Por Doria-Rose, NA, Georgiev, I, Staupe, RP, O'Dell, S, Chuang, G, Gorman, J, McLellan, JS, Pancera, M, Bonsignori, M, Haynes, BF, Burton, DR, Koff, WC, Kwong, PD, Mascola, JR
Publicado em 2012

Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption

Por Bar, K.J., Sneller, M.C., Harrison, L.J., Justement, J.S., Overton, E.T., Petrone, M.E., Salantes, D.B., Seamon, C.A., Scheinfeld, B., Kwan, R.W., Learn, G.H., Proschan, M.A., Kreider, E.F., Blazkova, J., Bardsley, M., Refsland, E.W., Messer, M., Clarridge, K.E., Tustin, N.B., Madden, P.J., Oden, K.S., O’Dell, S.J., Jarocki, B., Shiakolas, A.R., Tressler, R.L., Doria-Rose, N.A., Bailer, R.T., Ledgerwood, J.E., Capparelli, E.V., Lynch, R.M., Graham, B.S., Moir, S., Koup, R.A., Mascola, J.R., Hoxie, J.A., Fauci, A.S., Tebas, P., Chun, T.-W.
Publicado no N Engl J Med (2016)